Novartis

Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift
BioSpace
Wed, 03/15/23 - 11:17 am
Mediar Therapeutics
Novartis
Pfizer
fibrosis
After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra
Fierce Pharma
Tue, 03/14/23 - 11:30 am
Novartis
Xiidra
ophthalmology
Seeking to boost shareholder returns, Novartis readies new $11B buyback round
Fierce Pharma
Mon, 03/13/23 - 04:42 pm
Novartis
share repurchase
Sandoz, betting on biosimilar sales, to build new production plant
BioPharma Dive
Thu, 03/9/23 - 09:15 pm
Sandoz
Novartis
drug manufacturing
Slovenia
biosimilars
Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter
Fierce Pharma
Wed, 03/8/23 - 09:51 am
Novartis
Pharma CEOs
Vas Narasimhan
executive pay
restructuring
Novartis ready to head for deep space with Voyager after a year 'kicking the tires'
Fierce Biotech
Mon, 03/6/23 - 11:41 am
Novartis
Voyager Therapeutics
Novartis takes step toward expanding supply of in-demand cancer drug
Biopharma Dive
Sun, 03/5/23 - 03:09 pm
Novartis
Pluvicto
prostate cancer
Spotlight – What is next in Nash
EP Vantage
Fri, 03/3/23 - 10:02 am
NASH
clinical trials
89Bio
Arrowhead Pharmaceuticals
Can-Fite BioPharma
Ewopharma
Hepagene Therapeutics
JNJ
Ligand Pharmaceuticals
Madrigal Pharmaceuticals
Merck
NGM Biopharmaceuticals
NorthSea Therapeutics
Novartis
Sagimet Biosciences
Terns Pharmaceuticals
Viking Therapeutics
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fierce Biotech
Sun, 02/26/23 - 10:20 pm
Fulcrum Therapeuticsl
FDA
sickle cell disease
clinical trials
FDX-6058
Novartis
Sangamo
Graphite Bio
Novartis backs away from NASH, furthering its research revamp
BioPharma Dive
Sun, 02/26/23 - 10:16 pm
Novartis
NASH
Pliant Therapeutics
PLN-1474
Novartis Drops SCD Gene Therapy Program with Intellia
BioSpace
Fri, 02/24/23 - 09:03 am
Novartis
sickle cell disease
Intellia Therapeutics
CRISPR
gene editing
Novartis, Roche avoid $475M antitrust fine in French appeals court
Fierce Pharma
Mon, 02/20/23 - 12:57 pm
Novartis
Roche
antitrust
Lucentis
Novartis loses $940M arbitration case against Mitsubishi Chemical over Gilenya royalties
Fierce Pharma
Mon, 02/20/23 - 12:42 pm
Novartis
Mitsubishi Chemical
multiple sclerosis
MS
Supreme Court
legal
patents
Gilenya
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Tue, 02/7/23 - 12:22 pm
Sandoz
Novartis
biosimilars
osteoporosis
Prolia
Xgeva
FDA
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Fierce Pharma
Wed, 02/1/23 - 10:22 pm
Novartis
Vas Narasimhan
PhRMA
Inflation Reduction Act
PBMs
small molecule drugs
Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
Yahoo/Benzinga
Wed, 02/1/23 - 10:39 am
Novartis
earnings
Sandoz
Novartis' approved sickle cell disease drug fails to beat placebo in PhIII
Endpoints
Sun, 01/29/23 - 01:23 pm
Novartis
sickle cell disease
Adakveo
clinical trials
Anthos doubles down on its novel blood thinner
EP Vantage
Fri, 01/27/23 - 10:34 am
Anthos
Novartis
Factor XI inhibitor
bloodthinners
abelacimab
Could This Be Novartis' Next Blockbuster Medicine?
Motley Fool
Fri, 01/27/23 - 10:27 am
Novartis
iptacopan
PNH

Pages